论文部分内容阅读
目的:对采用大剂量纳洛酮进行治疗的重型颅脑损伤患者的临床疗效进行分析和探讨。方法:随机抽选2011年04月~2014年03月之间,我院收治的重型颅脑损伤患者52例,并回顾性分析和比较他们的临床诊治方法和临床效果。结果:经过临床统计,观察组的GCS(格拉斯哥)评分(13.91±2.03)以及临床总疗效(92.31%)均明显高于对照组(11.10±2.04,61.54%),组间比较具有统计学意义(P<0.05)。结论:应用大剂量纳洛酮进行重型颅脑损伤患者的辅助治疗,其临床总有效率高,患者症状改善良好。因而,它是一种科学、有效、理想的临床治疗方法。
Objective: To analyze and discuss the clinical curative effect of heavy craniocerebral injury patients treated with high-dose naloxone. Methods: A total of 52 patients with severe craniocerebral injury who were admitted to our hospital from April 2011 to March 2014 were randomly selected and retrospectively analyzed and compared with their clinical diagnosis and treatment. Results: According to clinical statistics, GCS (Glasgow) score (13.91 ± 2.03) and total clinical efficacy (92.31%) in the observation group were significantly higher than those in the control group (11.10 ± 2.04,61.54%), with statistical significance P <0.05). Conclusion: The adjuvant therapy of high-dose naloxone for patients with severe craniocerebral injury has a high total clinical efficiency and good symptoms. Therefore, it is a scientific, effective and ideal clinical treatment.